Alibaba Health Information Technology Limited (ALBBY)

Market Cap	12.78B +77.8%
Revenue (ttm)	4.64B +16.5%
Net Income	271.11M +60.0%
EPS	0.02 +51.8%
Shares Out	n/a
PE Ratio	47.13
Forward PE	31.55
Dividend	n/a
Ex-Dividend Date	n/a

Volume	355
Average Volume	822
Open	15.23
Previous Close	n/a
Day's Range	15.00 - 15.23
52-Week Range	8.95 - 19.45
Beta	1.67
RSI	49.60
Earnings Date	Feb 25, 2026

About ALBBY

Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. The company offers a range of prescription and over-the-counter drugs, nutritional supplements, medical devices, contact lenses, healthcare food, adult and family planning products, and various other health-related products. It also provides medical and healthcare services, including medical checkups, medical c...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 1998
• Employees: 1,357
• Stock Exchange: OTCMKTS
• Ticker Symbol: ALBBY

Financial Performance

In fiscal year 2025, ALBBY's revenue was 30.60 billion, an increase of 13.22% compared to the previous year's 27.03 billion. Earnings were 1.43 billion, an increase of 62.14%.

Financial numbers in CNY